XML 71 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stockholders' Equity (Tables)
12 Months Ended
Jan. 03, 2020
Schedule of Share-based Compensation, Fair Value of Stock-Based Compensation Granted

The following table represents the fair value of stock-based compensation granted during the year ended 2019 (in thousands):

 

 

 

Fair Value

 

Stock options

 

$

14,813

 

Restricted stock units

 

 

728

 

Restricted stock

 

 

313

 

Total stock-based compensation expense

 

$

15,854

 

 

Schedule of Compensation Cost

The cost that has been charged against income for stock-based compensation is set forth below (in thousands):

 

 

 

Years Ended

 

 

 

2019

 

 

2018

 

 

2017

 

Employee stock option

 

$

8,144

 

 

$

4,013

 

 

$

1,731

 

Restricted stock

 

 

320

 

 

 

274

 

 

 

186

 

Restricted stock units

 

 

1,905

 

 

 

2,120

 

 

 

1,226

 

Nonemployee stock options

 

 

178

 

 

 

355

 

 

 

18

 

Total stock-based compensation expense

 

$

10,547

 

 

$

6,762

 

 

$

3,161

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation expense in the following categories (in thousands):

 

 

 

Years Ended

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of sales

 

$

52

 

 

$

15

 

 

$

8

 

General and administrative

 

 

4,010

 

 

 

2,635

 

 

 

1,487

 

Marketing and selling

 

 

3,318

 

 

 

1,805

 

 

 

805

 

Research and development

 

 

3,167

 

 

 

2,307

 

 

 

861

 

Total stock-based compensation expense, net

 

 

10,547

 

 

 

6,762

 

 

 

3,161

 

Amounts capitalized as part of inventory

 

 

1,017

 

 

 

637

 

 

 

372

 

Total stock-based compensation expense, gross

 

$

11,564

 

 

$

7,399

 

 

$

3,533

 

Schedule of Unrecognized Compensation Cost, Non-Vested Stock-Based Compensation Arrangements

As of January 3, 2020, total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Plan were as follows (in thousands):

 

 

 

2019

 

Stock options

 

$

14,817

 

Restricted stock and restricted stock units

 

 

594

 

Total unrecognized stock-based compensation cost

 

$

15,411

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

 

Years Ended

 

 

 

2019

 

 

2018

 

 

2017

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

53

%

 

 

53

%

 

 

57

%

Risk-free interest rate

 

 

2.40

%

 

 

2.71

%

 

 

1.96

%

Expected term (in years)

 

 

5.66

 

 

 

5.72

 

 

 

5.67

 

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of option activity under the Plan for the year ended January 3, 2020 is presented below:

 

 

 

Shares

(in 000’s)

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term (years)

 

 

Aggregate

Intrinsic

Value

(in 000’s)

 

Outstanding at December 28, 2018

 

 

3,920

 

 

$

11.80

 

 

 

 

 

 

 

 

 

Granted

 

 

824

 

 

 

35.40

 

 

 

 

 

 

 

 

 

Exercised

 

 

(388

)

 

 

8.92

 

 

 

 

 

 

 

 

 

Forfeited or expired

 

 

(30

)

 

 

25.87

 

 

 

 

 

 

 

 

 

Outstanding at January 3, 2020

 

 

4,326

 

 

$

16.46

 

 

 

6.51

 

 

$

78,995

 

Exercisable at January 3, 2020

 

 

3,047

 

 

$

10.66

 

 

 

5.54

 

 

$

72,393

 

Share-based Compensation, Performance Shares Award Unvested Activity

A summary of unvested options activity under the Plan for the year ended January 3, 2020 was as follows:

 

 

 

Shares

(in 000’s)

 

 

Weighted-

Average

Grant-Date

Fair Value

 

Unvested at December 28, 2018

 

 

1,260

 

 

$

9.67

 

Granted

 

 

824

 

 

 

17.95

 

Forfeited or expired

 

 

(30

)

 

 

13.29

 

Vested

 

 

(775

)

 

 

8.83

 

Unvested at January 3, 2020

 

 

1,279

 

 

$

15.44

 

Summary of Weighted Average Grant Date Fair Value of Options Granted and Total intrinsic Value of options Exercised

The weighted average grant date fair value of options granted and the total intrinsic value of options exercised were as follows:

 

 

 

Years Ended

 

 

 

2019

 

 

2018

 

 

2017

 

Weighted-average grant-date fair value

 

$

17.95

 

 

$

11.95

 

 

$

5.42

 

Intrinsic value of options (in thousands)

 

$

9,955

 

 

$

13,699

 

 

$

3,065

 

 

Restricted Stock  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of restricted stock activity under the Plan for the year ended January 3, 2020 was as follows:

 

 

 

Shares

(in 000’s)

 

 

Weighted-

Average Grant-

Date Fair Value

 

Outstanding at December 28, 2018

 

 

11

 

 

$

29.80

 

Granted

 

 

11

 

 

 

29.39

 

Vested

 

 

(11

)

 

 

29.80

 

Outstanding at January 3, 2020

 

 

11

 

 

$

29.39

 

Restricted Stock Units (RSUs)  
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity

A summary of restricted stock units’ activity under the Plan for the year ended January 3, 2020 was as follows:

 

 

 

Units

(in 000’s)

 

 

Weighted-

Average Grant-

Date Fair Value

 

Outstanding at December 28, 2018

 

 

322

 

 

$

10.46

 

Granted

 

 

19

 

 

 

37.98

 

Vested

 

 

(229

)

 

 

12.58

 

Forfeited or expired

 

 

(8

)

 

 

11.57

 

Outstanding at January 3, 2020

 

 

104

 

 

$

10.79